|
|
|
PERSPECTIVE
Laboratory for Pluripotent Cell Studies, RIKEN Center for Developmental Biology (CDB), Kobe, Hyogo 650-0047, Japan
Pluripotency, the ability of a cell to give rise to all of the cells of an organism, is a fascinating and mysterious characteristic of embryonic stem (ES) cells. Recent extensive molecular studies of mouse ES cells have revealed the roles played by transcription factor networks and epigenetic processes in the maintenance of ES cell pluripotency (Niwa 2007
). However, no direct evidence to connect these two mechanisms had been reported until in the previous issue of Genes & Development, in which Loh et al. (2007)
presented new evidence concerning this missing link.
| Transcription factor network to maintain pluripotency |
|---|
|
|
|---|
| Epigenetic mechanism to maintain pluripotency |
|---|
|
|
|---|
There have been no reports to date identifying the mechanisms by which ES cells are able to generate an open chromatin state at the genome-wide level, although there are several possible mechanisms for keeping chromatin in an open configuration. As the acetylation of histone H3 and H4 is important in transcriptional activation, both by promoting open chromatin structural rearrangements and by competing with silent histone marks such as di- and trimethylation of Lys 9 of histone H3 (H3K9me2 and H3K9me3), it follows that either the activation of histone acetyltransferases (HATs) or inactivation of histone deacetylases (HDACs) should contribute to the rearrangement of chromatin into an open conformation. Maintenance of H3K4me3 by activation of a histone methyltransferase (HMTase) and/or inactivation of a histone demethylase (HDMase) specific to this modification would presumably result in keeping chromatin open. It was recently reported that unmethylated H3K4 is specifically recognized by a member of the DNA methyltransferase (Dnmt) family, Dnmt3l (Ooi et al. 2007
). Dnmt3l lacks the activity of other Dnmts, but it recruits Dnmt3a, which functions to activate de novo methylation of DNA. DNA methylation is recognized by methyl DNA-binding proteins, such as MeCP2 and MBD1, and triggers the formation of heterochromatin by recruiting heterochromatin proteins (HP). Since ES cells express high levels of both Dnmt3l and Dnmt3a, this mechanism should be countered by proteins that would maintain the methylation of H3K4 in order to keep chromatin in its open configuration. Conversely, exclusion of repressive histone marks—such as H3K9me2, H3K9me3, and H3K27me3, which recruit HPs to form heterochromatin by activating HDM and/or inactivating HMTs specific for these modifications—represents a possible mechanism for generating open chromatin in ES cells.
Until recently, the enzymatic activity of a HDMase in the demethylation of a methylatd histone lysine was only identified in the LSD protein, which removes H3K4me1 and H3K4me2 (Klose and Zhang 2007
). However, in a breakthrough finding reported in 2006, Tsukada et al. (2006)
used a biochemical approach to purify a robust HDMase activity with specificity toward Lys 36 of histone H3 from mammalian cells, and identified Jumonji-C (JmjC) domain-containing histone demethylase 1A (JHDM1A) as the molecule responsible for this HDMase activity. Using the same strategy, a novel H3K9-specific HDMase was identified as JHDM2A (Yamane et al. 2006
). The JmjC domain was then to be the catalytic domain of HDMase (Klose and Zhang 2007
). Jumonji (abbreviated Jmj) means "cruciform" in Japanese, in reference to the morphological phenotype of Jmj mutant mice, in which the normal neural groove is crossed by abnormal grooves on the neural plates (Takeuchi et al. 1995
). There are multiple genes containing JmjC domains in the mouse genome, and JHDM3/JMJD2 enzymes have been identified as HDMases that preferentially demethylate H3K9me3, H3K9me2, H3K36me3, and H3K36me2 (Klose et al. 2006
), although their functions in ES cells have not yet been assessed.
| JmjC members cross genetic and epigenetic mechanisms to maintain pluripotency |
|---|
|
|
|---|
But what of the roles of the other three transcription factors in modulating the epigenetics of pluripotent cells? Since Sox2 and Klf4 function cooperatively with Oct3/4 (Nakatake et al. 2006
), it seems evident that research should focus on elucidating the function of Oct3/4, the pivotal gene in this particular network. Lists of the target genes of Oct3/4 have been developed using a variety of approaches (Boyer et al. 2005
; Loh et al. 2006
; Matoba et al. 2006
). The comparison of global gene expression profiling with cDNA microarrays of ES cells after repression of Oct3/4 and chromatin immunoprecipitation (ChIP), in combination with a genome-wide location technique for Oct3/4, yielded 372 putative primary target genes, which contain several genes encoding epigenetic modifiers (Matoba et al. 2006
). From these data, in the previous issue of Genes & Development, Loh et al. (2007)
identified the two JmjC family members encoding HDMases, Jmjd1a and Jmjd2c, as Oct3/4 targets. They first identified clusters of Oct3/4-binding sites by ChIP-paired end ditag analysis (ChIP-PET) and confirmed their functional significance for transcriptional activation by reporter assay. Depletion of Jmjd1a by small interfering RNA (siRNA) in ES cells resulted in the induction of differentiation with a global increase in H3K9me2, whereas depletion of Jmjd2c induced differentiation with a global increase in H3K9me3, confirming that their HDMase activity is linked to the maintenance of pluripotency. They next identified the genes whose expression was affected by depletion of these JmjC genes by cDNA microarray analyses. One of the genes down-regulated after depletion of Jmjd1a is Tcl1, which encodes the adaptor protein of Akt (Thymoma viral proto-oncogene 1) that enhances its enzymatic activity (Teitell 2005
). Akt1 is a key kinase in the Ras/PI3K/Akt1 signaling pathway that is important for propagation of mouse ES cells. It has been reported that Tcl1 is expressed in ES cells in a stem cell-specific manner, and that its promoter activity is positively regulated by Oct3/4 (Matoba et al. 2006
). Moreover, knockout of Tcl1 in mouse embryos leads to preimplantation lethality (Narducci et al. 2002
), and knockdown of Tcl1 in ES cells results in either the induction of differentiation or the repression of proliferation (Ivanova et al. 2006
; Matoba et al. 2006
). Loh et al. (2007)
found that the level of H3K9me2 and H3K9me3 in the Tcl1 promoter increased in Jmjd1a knockdown ES cells with a reduction in Oct3/4 recruitment, and that Jmjd1a proteins are recruited to this promoter, indicating that removal of H3K9me2 from the promoter by Jmjd1a is required for proper Oct3/4-dependent transcriptional activation of Tcl1 in ES cells. Interestingly, Tcl1 is functionally significant as the target of Jmjd1a, since the ectopic expression of Tcl1 prevents the differentiation of ES cells induced by the depletion of Jmjd1a. They identified Nanog as the Jmjd2c target and confirmed the recruitment of Jmjd2c to the Nanog promoter. Depletion of Jmjd2c resulted in an increase of H3K9me3 with enrichment of HP1
, but left recruitment of Oct3/4 unaffected. Nanog also has functional significance as the target of Jmjd2c, because the ectopic expression of Nanog prevents differentiation of ES cells induced by depletion of Jmjd2c. These findings show that Oct3/4 activates transcription of target genes either directly as a transcriptional activator or indirectly by transcriptional activation of chromatin modifiers that keep target sites in an accessible chromatin conformation.
| Is pluripotency the default state? |
|---|
|
|
|---|
It is now possible to propose that the pluripotent state is a default state of genetic systems (Fig. 1). The transcription factor network to determine pluripotency might be self-organized by a positive feedback mechanism, and this also might be true for other transcription factor networks that confer differentiated phenotypes. Therefore, if all genetic information is freed from epigenetic repression, all transcription factors begin to establish their preferred network via self-activation. However, in such a scenario, the networks must be mutually exclusive in order to give rise to a single phenotype in any given cell. If exclusion occurs simply by chance, all phenotypes would arise with equal frequency. That said, it remains possible that one transcription factor network is extremely stable due to the extraordinary power of its positive feedback and its ability to repress other networks. In the first differentiation event in mouse development, trophectoderm is segregated from the pluripotent cell lineage via competition between two transcription factors—Oct3/4 and Cdx2 (Niwa et al. 2005
). These two transcription factors possess positive feedback loops that activate their own expression, respectively, and a complex formed by the two factors competes against the activation of both. In morula-stage embryos, Cdx2 might exclude Oct3/4 via a signal from polarized epithelium, while the opposite may occur in the inner cells lacking such a polarity signal, suggesting that pluripotency is dominant in the default state. The dominant character of the pluripotent network has been shown by cell fusion experiments. When pluripotent stem cells are fused to differentiated cells, the resulting tetraploid cells tend to acquire pluripotency (Tada et al. 2001
). Therefore, the ability of the pluripotent transcription factor network to promote an epigenetic mechanism to keep chromatin open may serve as an element of the positive feedback mechanism that maintains the network. This may be the reason why pluripotency can be established in somatic cell nuclei more easily than had been expected previously.
|
| Further genetics of the epigenetic mechanism in ES cells |
|---|
|
|
|---|
High levels of chromatin remodeling activity might also contribute to keeping chromatin open. The essential role of Snf2b (Brg1, Smarca4)—encoding a core component of the SWI/SNF and ISWI family remodeling complex—in the self-renewal of F9 embryonal carcinoma cells has been reported (Sumi-Ichinose et al. 1997
), and Smarcad1 belongs to the SNF2 family of DEAD/H-box-containing helicase superfamily and was identified as a putative primary target of Oct3/4 (Matoba et al. 2006
). The NuRD (nucleosome remodeling and histone deacetylation) complex component Mbd3 is required for the differentiation of ES cells, and it functions in the inner cell mass of the blastocyst to expand into ES cells in vitro (Kaji et al. 2007
). However, most of these genes are expressed ubiquitously, and careful analysis will be required to distinguish the functions specific to the maintenance of pluripotency from other housekeeping functions.
The hyperdynamics of architectural chromatin proteins has been pointed out as a unique characteristic of ES cells, and the nucleosome assembly factor HirA was proposed as one of the factors responsible for this feature, since HirA-null ES cells exhibit elevated levels of unbound histones and the formation of embryoid bodies is accelerated in these mutant cells (Meshorer et al. 2006
). In contrast to HirA, which acts as a chaperone of histone H3.3 in a DNA synthesis-independent manner, CAF1 acts as a chaperone of H3.1 in a DNA synthesis-dependent manner. It was recently reported that CAF1-null mouse embryos die at the 16-cell stage, suggesting it has an essential function in pluripotent cell populations (Houlard et al. 2006
). In addition, a novel epigenetic feature of ES cells was revealed by Szutorisz et al. (2006)
, who showed that the proteasome acts on specific regulatory regions in ES cells to prevent incorrect transcriptional initiation to restrict permissive transcriptional activity while keeping the genes in a potentiated state. This system might contribute to keeping the threshold level of the promoter activity high for significant gene expression, thereby allowing the exclusive activation of the pluripotent transcription factor network, a hypothesis that has yet to be functionally confirmed.
For all epigenetic mechanisms, an important unsolved question remains. It has been clearly shown that Jmjd1a and Jmjd2c do not remove methylation of H3K9 ubiquitously, but that they are instead recruited to specific target genes to modulate local chromatin structure. This target-specific function has been observed in the proteasome. Since proteins there lack the ability to recognize specific DNA sequences, they should be recruited to the target genes by interaction with transcription factors binding a specific sequence. But which sequence-specific transcription factors work to recruit them? One possible and interesting candidate is none other than Oct3/4. Oct3/4 works as a transcriptional activator via interaction with multiple transcription factors in a context-dependent manner. In the case of PRC2, the role of Oct3/4 in recruiting it to target sites was suggested by the overlap of their binding sites in the genome (Lee et al. 2006
). Oct3/4 cooperates with Sox2 in several cases, and with both Sox2 and Klf4 on a subset of target genes. In addition, cooperation with factor(s) other than Sox2 is suspected for the activation of the Zfp42 and Tcl1 promoters. Oct3/4 may recruit different JmjC family members in a cofactor-dependent manner. If so, the stability of the positive feedback mechanism, including both genetic and epigenetic factors, would be enhanced significantly. The solution of this puzzle will doubtless contribute to improving the efficiency of methods for establishing iPS cells, which may one day be used in the development of patient-specific cell therapies.
| Acknowledgments |
|---|
|
|
|---|
| Footnotes |
|---|
E-MAIL niwa{at}cdb.riken.jp; FAX 81-78-306-1929. ![]()
Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.1615707
| References |
|---|
|
|
|---|
Azuara, V., Perry, P., Sauer, S., Spivakov, M., Jorgensen, H.F., John, R.M., Gouti, M., Casanova, M., Warnes, G., Merkenschlager, M., et al. 2006. Chromatin signatures of pluripotent cell lines. Nat. Cell Biol. 8: 532–538.[CrossRef][Medline]
Bernstein, B.E., Mikkelsen, T.S., Xie, X., Kamal, M., Huebert, D.J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. 2006. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125: 315–326.[CrossRef][Medline]
Boyer, L.A., Lee, T.I., Cole, M.F., Johnstone, S.E., Levine, S.S., Zucker, J.P., Guenther, M.G., Kumar, R.M., Murray, H.L., Jenner, R.G., et al. 2005. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122: 947–956.[CrossRef][Medline]
Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S., and Smith, A. 2003. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113: 643–655.[CrossRef][Medline]
Ernst, P., Mabon, M., Davidson, A.J., Zon, L.I., and Korsmeyer, S.J. 2004. An Mll-dependent Hox program drives hematopoietic progenitor expansion. Curr. Biol. 14: 2063–2069.[CrossRef][Medline]
Glaser, S., Schaft, J., Lubitz, S., Vintersten, K., van der Hoeven, F., Tufteland, K.R., Aasland, R., Anastassiadis, K., Ang, S.L., and Stewart, A.F. 2006. Multiple epigenetic maintenance factors implicated by the loss of Mll2 in mouse development. Development 133: 1423–1432.
Houlard, M., Berlivet, S., Probst, A.V., Quivy, J.P., Hery, P., Almouzni, G., and Gerard, M. 2006. CAF-1 is essential for heterochromatin organization in pluripotent embryonic cells. PLoS Genet. 2: e181. doi: 10.1371/journal.pgen.0020181.[CrossRef][Medline]
Issaeva, I., Zonis, Y., Rozovskaia, T., Orlovsky, K., Croce, C.M., Nakamura, T., Mazo, A., Eisenbach, L., and Canaani, E. 2007. Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth. Mol. Cell. Biol. 27: 1889–1893.
Ivanova, N., Dobrin, R., Lu, R., Kotenko, I., Levorse, J., DeCoste, C., Schafer, X., Lun, Y., and Lemischka, I.R. 2006. Dissecting self-renewal in stem cells with RNA interference. Nature 442: 533–538.[CrossRef][Medline]
Kaji, K., Nichols, J., and Hendrich, B. 2007. Mbd3, a component of the NuRD co-repressor complex, is required for development of pluripotent cells. Development 134: 1123–1132.
Klose, R.J. and Zhang, Y. 2007. Regulation of histone methylation by demethylimination and demethylation. Nat. Rev. Mol. Cell Biol. 8: 307–318.[CrossRef][Medline]
Klose, R.J., Yamane, K., Bae, Y., Zhang, D., Erdjument-Bromage, H., Tempst, P., Wong, J., and Zhang, Y. 2006. The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36. Nature 442: 312–316.[CrossRef][Medline]
Knoepfler, P.S., Zhang, X.Y., Cheng, P.F., Gafken, P.R., McMahon, S.B., and Eisenman, R.N. 2006. Myc influences global chromatin structure. EMBO J. 25: 2723–2734.[CrossRef][Medline]
Lan, F., Bayliss, P.E., Rinn, J.L., Whetstine, J.R., Wang, J.K., Chen, S., Iwase, S., Alpatov, R., Issaeva, I., Canaani, E., et al. 2007. A histone H3 lysine 27 demethylase regulates animal posterior development. Nature doi: 10.1038/nature06192.
Lee, T.I., Jenner, R.G., Boyer, L.A., Guenther, M.G., Levine, S.S., Kumar, R.M., Chevalier, B., Johnstone, S.E., Cole, M.F., Isono, K., et al. 2006. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125: 301–313.[CrossRef][Medline]
Lin, W., Srajer, G., Evrard, Y.A., Phan, H.M., Furuta, Y., and Dent, S.Y. 2007. Developmental potential of Gcn5–/– embryonic stem cells in vivo and in vitro. Dev. Dyn. 236: 1547–1557.[CrossRef][Medline]
Loh, Y.H., Wu, Q., Chew, J.L., Vega, V.B., Zhang, W., Chen, X., Bourque, G., George, J., Leong, B., Liu, J., et al. 2006. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 38: 431–440.[CrossRef][Medline]
Loh, Y.-H., Zhang, W., Chen, X., Grorge, J., and Ng, H.-H. 2007. Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes & Dev. 21: 2545–2557.
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. 2007. Directly reprogrammed fibroblasts show grobal epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1: 55–70.[CrossRef]
Masui, S., Nakatake, Y., Toyooka, Y., Shimosato, D., Yagi, R., Takahashi, K., Okochi, H., Okuda, A., Matoba, R., Sharov, A.A., et al. 2007. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat. Cell Biol. 9: 625–635.[CrossRef][Medline]
Matoba, R., Niwa, H., Masui, S., Ohtsuka, S., Carter, M.G., Sharov, A.A., and Ko, M.S. 2006. Dissecting Oct3/4- regulated gene networks in embryonic stem cells by expression profiling. PLoS ONE 1: e26. doi: 10.1371/journal.pone.0000026.[CrossRef]
Meshorer, E., Yellajoshula, D., George, E., Scambler, P.J., Brown, D.T., and Misteli, T. 2006. Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev. Cell 10: 105–116.[CrossRef][Medline]
Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K., Murakami, M., Takahashi, K., Maruyama, M., Maeda, M., and Yamanaka, S. 2003. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113: 631–642.[CrossRef][Medline]
Montgomery, N.D., Yee, D., Chen, A., Kalantry, S., Chamberlain, S.J., Otte, A.P., and Magnuson, T. 2005. The murine polycomb group protein Eed is required for global histone H3 lysine-27 methylation. Curr. Biol. 15: 942–947.[CrossRef][Medline]
Nakatake, Y., Fukui, N., Iwamatsu, Y., Masui, S., Takahashi, K., Yagi, R., Yagi, K., Miyazaki, J.I., Matoba, R., Ko, M.S., et al. 2006. Klf4 cooperates with Oct3/4 and Sox2 to activate the Lefty1 core promoter in embryonic stem cells. Mol. Cell. Biol 26: 7772–7782.
Narducci, M.G., Fiorenza, M.T., Kang, S.M., Bevilacqua, A., Di Giacomo, M., Remotti, D., Picchio, M.C., Fidanza, V., Cooper, M.D., Croce, C.M., et al. 2002. TCL1 participates in early embryonic development and is overexpressed in human seminomas. Proc. Natl. Acad. Sci. 99: 11712–11717.
Niwa, H. 2007. How is pluripotency determined and maintained? Development 134: 635–646.
Niwa, H., Toyooka, Y., Shimosato, D., Strumpf, D., Takahashi, K., Yagi, R., and Rossant, J. 2005. Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation. Cell 123: 917–929.[CrossRef][Medline]
Ooi, S.K., Qiu, C., Bernstein, E., Li, K., Jia, D., Yang, Z., Erdjument-Bromage, H., Tempst, P., Lin, S.P., Allis, C.D., et al. 2007. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 448: 714–717.[CrossRef][Medline]
Pasini, D., Bracken, A.P., Hansen, J.B., Capillo, M., and Helin, K. 2007. The polycomb group protein Suz12 is required for embryonic stem cell differentiation. Mol. Cell. Biol. 27: 3769–3779.
Sumi-Ichinose, C., Ichinose, H., Metzger, D., and Chambon, P. 1997. SNF2
-BRG1 is essential for the viability of F9 murine embryonal carcinoma cells. Mol. Cell. Biol. 17: 5976–5986.[Abstract]
Szutorisz, H., Georgiou, A., Tora, L., and Dillon, N. 2006. The proteasome restricts permissive transcription at tissue-specific gene loci in embryonic stem cells. Cell 127: 1375–1388.[CrossRef][Medline]
Tada, M., Takahama, Y., Abe, K., Nakatsuji, N., and Tada, T. 2001. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr. Biol. 11: 1553–1558.[CrossRef][Medline]
Takahashi, K. and Yamanaka, S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663–676.[CrossRef][Medline]
Takeuchi, T., Yamazaki, Y., Katoh-Fukui, Y., Tsuchiya, R., Kondo, S., Motoyama, J., and Higashinakagawa, T. 1995. Gene trap capture of a novel mouse gene, jumonji, required for neural tube formation. Genes & Dev. 9: 1211–1222.
Teitell, M.A. 2005. The TCL1 family of oncoproteins: Co-activators of transformation. Nat. Rev. Cancer 5: 640–648.[CrossRef][Medline]
Tsukada, Y., Fang, J., Erdjument-Bromage, H., Warren, M.E., Borchers, C.H., Tempst, P., and Zhang, Y. 2006. Histone demethylation by a family of JmjC domain-containing proteins. Nature 439: 811–816.[CrossRef][Medline]
Yamanaka, S. 2007. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1: 39–50.[CrossRef]
Yamane, K., Toumazou, C., Tsukada, Y., Erdjument-Bromage, H., Tempst, P., Wong, J., and Zhang, Y. 2006. JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell 125: 483–495.[CrossRef][Medline]
Yuan, H., Corbi, N., Basilico, C., and Dailey, L. 1995. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes & Dev. 9: 2635–2645.
Related Article
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Genes & Dev. 2007 21: 2545-2557.
This article has been cited by other articles:
![]() |
M. Ekici, M. Hohl, F. Schuit, A. Martinez-Serrano, and G. Thiel Transcription of Genes Encoding Synaptic Vesicle Proteins in Human Neural Stem Cells: CHROMATIN ACCESSIBILITY, HISTONE METHYLATION PATTERN, AND THE ESSENTIAL ROLE OF REST J. Biol. Chem., April 4, 2008; 283(14): 9257 - 9268. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||